https://akavatx.com/latest-news/ 2026-08-11T12:26:32+00:00 https://akavatx.com/latest-news/license-agreement-with-northwestern-university-for-akv9-has-been-completed/ 2021-10-22T07:05:06+00:00 https://akavatx.com/wp-content/uploads/2022/03/northwesternuniversity_logo-e1734450618437.png https://akavatx.com/latest-news/akava-receives-orphan-drug-designation-status-for-akv9/ 2022-07-06T05:32:28+00:00 https://akavatx.com/wp-content/uploads/2022/08/fda_logoSquare-768x768-1.jpeg https://akavatx.com/wp-content/uploads/2022/07/fda_logo.png https://akavatx.com/latest-news/akava-therapeutics-inc-shares-recent-data-suggesting-that-akv9-acts-on-a-common-mechanism-involved-in-both-alzheimers-disease-ad-and-amyotrophic-lateral-sclerosis-als/ 2026-08-11T12:12:27+00:00 https://akavatx.com/wp-content/uploads/2023/08/BW.png https://akavatx.com/latest-news/remarkable-als-drug-may-also-work-on-alzheimers/ 2026-08-11T12:13:11+00:00 https://akavatx.com/wp-content/uploads/2025/04/Newsweek-logo.jpg https://akavatx.com/latest-news/akava-therapeutics-inc-congratulates-sab-chair-dr-hande-ozdinler-founder-dr-richard-b-silverman-and-dr-william-klein-on-their-recent-grant-of-7-3-million-from-the-national-institute-on-aging/ 2026-08-11T12:13:33+00:00 https://akavatx.com/wp-content/uploads/2023/08/BW.png https://akavatx.com/latest-news/national-institute-on-aging-invests-an-additional-7-3-million-into-nu-9/ 2026-08-11T12:14:00+00:00 https://akavatx.com/wp-content/uploads/2022/03/northwesternuniversity_logo-e1734450618437.png https://akavatx.com/latest-news/akava-therapeutics-inc-announces-fda-clearance-of-investigational-new-drug-application-for-the-treatment-of-amyotrophic-lateral-sclerosis/ 2026-08-11T12:14:27+00:00 https://akavatx.com/wp-content/uploads/2023/08/BW.png https://akavatx.com/latest-news/richard-b-silverman-elected-to-the-national-academy-of-sciences/ 2026-08-11T12:14:57+00:00 https://akavatx.com/wp-content/uploads/2023/05/national-academy-of-sciences-logo.jpg https://akavatx.com/latest-news/drug-hunter-interview/ 2026-08-11T12:15:19+00:00 https://akavatx.com/wp-content/uploads/2023/01/dhlogo.png https://akavatx.com/latest-news/a-long-swim/ 2026-08-11T12:15:43+00:00 https://akavatx.com/wp-content/uploads/2023/01/A-Long-Swim-Logo-FINAL-1023x622-1.png https://akavatx.com/latest-news/als-drug-breakthrough-shows-promise-in-animal-studies/ 2026-08-11T12:20:27+00:00 https://akavatx.com/wp-content/uploads/2022/07/denverNews.png https://akavatx.com/latest-news/this-time-around-lyricas-inventor-is-developing-his-northwestern-discoveries-at-his-own-biotech/ 2026-08-11T12:23:25+00:00 https://akavatx.com/wp-content/uploads/2022/05/Endpoints-News-logo.png https://akavatx.com/latest-news/nu-9-improves-health-of-hsod1g93a-mouse-upper-motor-neurons-in-vitro-especially-in-combination-with-riluzole-or-edaravone/ 2026-08-11T12:24:43+00:00 https://akavatx.com/wp-content/uploads/2022/03/AKAVA-News-e1650549917908.png https://akavatx.com/latest-news/akava-founder-richard-b-silverman-receives-2021-tetrahedron-prize/ 2026-08-11T12:26:32+00:00 https://akavatx.com/wp-content/uploads/2022/03/Richard.jpg